Mice undergoing dendritic cell therapy had more CD4+ T cells in tumor-draining lymph nodes and tumors and a higher fraction of CD4+ T cells expressed an activated phenotype what shows that dendritic cells were effectively stimulating Ep63K-specific T cells. Here, CD4 is linked to neoplasm.